Home
>
National Drug Code (NDC)
>
Agrylin
Agrylin - 54092-063-01 - (anagrelide hydrochloride)
Drug Information of Agrylin
| Product NDC: | 54092-063 |
| Proprietary Name: | Agrylin |
| Non Proprietary Name: | anagrelide hydrochloride |
| Active Ingredient(s): | .5 mg/1 & nbsp; anagrelide hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Agrylin
| Product NDC: | 54092-063 |
| Labeler Name: | Shire US Manufacturing Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020333 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19970314 |
Package Information of Agrylin
| Package NDC: | 54092-063-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (54092-063-01) |
NDC Information of Agrylin
| NDC Code | 54092-063-01 |
| Proprietary Name | Agrylin |
| Package Description | 100 CAPSULE in 1 BOTTLE (54092-063-01) |
| Product NDC | 54092-063 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | anagrelide hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19970314 |
| Marketing Category Name | NDA |
| Labeler Name | Shire US Manufacturing Inc. |
| Substance Name | ANAGRELIDE HYDROCHLORIDE |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
